The miRNAs targeted the WNT antagonist Dickkopf WNT signaling pathway inhibitor 3 (DKK3) and the Notch suppressor Endocytic Adaptor Protein (NUMB) in the cancer cells that remained viable following chemotherapy. Here, DKK3 is linked to cancer.